Tenon Medical regained Nasdaq compliance with the $2.5M minimum stockholders’ equity requirement after a $4.2M public offering.

Key Highlights:

  • Nasdaq notified Tenon Medical on July 17, 2026 that it had regained compliance with the $2.5M equity rule.
  • Company’s July 10 Form 8-K stated the July 1, 2026 $4.2M public offering of common stock and warrants restored compliance.
  • If Tenon Medical fails to evidence compliance in its 10-Q for period ending Sept 30, 2026, it may face delisting (subject to appeal).
  • Press release attached as Exhibit 99.1 to the 8-K; disclosure furnished, not filed, and contains forward-looking statements.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.